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The synthesis of cytosine deaminase in Salmonella typhimurium is repressed by
pyrimidines. This repression is mediated by both a uridine and a cytidine
compound, indicating a distinct difference in the regulation of synthesis of
cytosine deaminase from the regulation of the de novo pyrimidine pathway
enzymes. A salvage role for the enzyme in pyrimidine metabolism is postulated.
Cytosine deaminase (cytosine aminohydro-
lase; EC 3.5.4.1) catalyzes the hydrolytic deami-
nation of cytosine to uracil and NH3 (2, 6, 14). In
Salmonella typhimurium, the enzyme is en-
coded by the gene cod (Fig. 1), which is located
at the 69-min position of the bacterial chromo-
some (15). Although numerous studies (1, 10, 16,
18) have examined the regulation of expression
of the genes pyrA through pyrF (Fig. 1), which
encode the six de novo pyrimidine pathway
enzymes in S. typhimurium, it is uncertain
whether such regulation exists for the cod gene
in this microorganism. Cytosine deaminase syn-
thesis has been found to be inducible in Myco-
bacterium (8), whereas its expression in Esche-
richia coli (11) is not under the control of the
cytR gene or the deoR gene, and the four deo
genes, along with udp and cdd, have been shown
to be controlled by cytR and deoR (17). Whether
the function of cytosine deaminase in pyrimidine
metabolism is related to the anabolism of pyrimi-
dine nucleotides or the catabolism of pyrimidine
bases is the subject of this brief report. When the
partial characterization of an enzyme activity
capable of degrading CMP to cytosine was re-
ported for S. typhimurium (3), an investigation
of the regulation of cytosine deaminase synthe-
sis seemed appropriate, since cytosine deami-
nase might be involved in a recycling pathway to
replenish pyrimidine nucleotide levels. Here we
present evidence that repression of cytosine
deaminase synthesis by both a uridine and a
cytidine compound occurs in S. typhimurium.
This finding is consistent with the enzyme being
involved in pyrimidine biosynthesis and en-
hances the possibility of the salvage pathway.
The S. typhimurium strains employed are list-
ed in Table 1. Coomassie brilliant blue G-250
t Present address: Department of Molecular and Medical
Microbiology, College of Medicine, University of Arizona,
Tucson, AZ 85724.
was purchased from Eastman Organic Chemi-
cals, Rochester, N.Y., and the remaining re-
agents were obtained from Sigma Chemical Co.,
St. Louis, Mo.
To test for cytosine deaminase synthesis being
induced by pyrimidines in S. typhimurium, the
wild-type strain LT2 was grown in minimal
medium with various pyrimidine supplements
(Table 2). While not affecting the generation
time of the strain (51 min), the presence of
pyrimidines in the medium decreased cytosine
deaminase activity, indicating no induction of
synthesis by uracil, cytosine, or uridine. It can
be concluded that cytosine deaminase is not a
cyt-enzyme, since cytR gene expression can be
induced by uridine in S. typhimurium (13).
The previous data indicated repression of cy-
tosine deaminase rather than induction. One
index of repression of enzyme synthesis by
pyrimidine compounds would be the elevation of
the enzyme activity in question after the starva-
tion of a pyrimidine-requiring strain for uracil (4,
18). From the data shown in Table 3, it can be
seen that the arginine- and uracil-requiring
strain, S2 (51-min generation time), after being
starved for uracil for 90 min, had a cytosine
deaminase activity that was about 2.3-fold high-
er than the activity found when the strain was
grown in the presence of uracil (under repressing
conditions). This derepression of cytosine deam-
inase synthesis after pyrimidine limitation con-
firmed repression as the regulation involved. To
differentiate between repression by a uridine and
a cytidine compound, it was necessary to use the
arginine-, uracil-, and cytidine-requiring strain
JL1055. This strain, having been constructed
specifically to allow the independent manipula-
tion of uridine and cytidine nucleotide pool
levels within S. typhimurium cells, enables the
identification of a uridine or a cytidine com-
pound as a corepressor of synthesis (12). The
resultant activities that were found after a 90-
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TABLE 1. Strains employed
Strain Genotype'" Source
LT2 Wild type B. N. Ames
KD1109 cdd4 (10)
HD11-AE2 pyrHIl cdd4 gaIE2 R. A. Kelln
S2 pyrA81 (19)
JL1055 pyrA81 pyrG cdd udp (12)
a All strains are derivatives of S. typhimurium LT2.
Genetic nomenclature is that of Sanderson and Hart-
man (15).
min starvation of strain JL1055 cells (75-min
generation time) for uridine nucleotides, cyti-
dine nucleotides, or both types of nucleotides
were compared with the fully repressed activity
(grown in uracil and cytidine medium) of this
strain (Table 3). A threefold derepression of
cytosine deaminase synthesis was noted for all
of the pyrimidine starvation conditions exam-
ined. This finding suggests that both a uridine
and a cytidine compound are repressing metabo-
lites of cod expression in S. typhimurium.
To ensure that the pyrimidine starvation con-
ditions used were not causing nonspecific dere-
pression of enzyme synthesis, cytosine deami-
nase was assayed in a UMP kinase (EC 2.7.4.4)
mutant strain and in an isogenic strain harboring
a functional UMP kinase gene (Table 2). As with
previous studies in S. typhimurium (10, 16), a
defective UMP kinase strain, HD11-AE2, was
chosen for this analysis since a growing cell
population of such a strain contains greatly
increased (i.e., derepressed) activities of those
enzymes repressed by pyrimidine compounds.
This increase is due to the inability of pyrH
strains to maintain wild-type (i.e., pyrH+) levels
of UDP (0.30 and 0.66 p.mol/g [dry weight] for
pyrH and pyrH+, respectively) and hence, UTP
(2.52 and 3.42 ,umol/g [dry weight] for pyrH and
pyrH', respectively). Thus, a partial starvation
is set up within the bacterial cell. The isogenic
pyrH+ strain KD1109 serves as a control since
its pyrimidine ribonucleotide levels are not al-
tered by a pyrH mutation and thus contain
normal levels of UDP and UTP (10).
Pyrimidine additions to minimal medium had
little effect on the generation time of either strain
HD11-AE2 (76 min) or strain KD1109 (62 min).
By comparing cytosine deaminase levels in
strains HD1 1-AE2 and KD1 109, it is evident that
the pyrH strain contained approximately four
times the activity of its isogenic pyrH' strain
(Table 2). Not only did this observation indicate
derepression of enzyme synthesis, but it ap-
peared that a uridine nucleotide might be the
primary corepressor. Previous nucleotide pool
studies with the pyrHll strain suggested that
this may be the case, since the uridine nucleo-
tide levels in the strain were significantly lower,
whereas its cytidine nucleotide levels were nor-
mal (relative to levels in a pyrH' strain) (9, 10).
In strain KD1109, the reduction of cytosine
deaminase activity by 32% with uracil in the
medium also suggests repression by a uridine
nucleotide (Table 2). In strain HD11-AE2, ura-
cil-containing medium had only a nominal effect
on enzyme activity (Table 2), as might be ex-
pected, since uracil could not be converted
beyond the monophosphate level in a pyrH
TABLE 2. Effect of pyrimidines on cytosine
deaminase levels in strains LT2, KD1109, and
HD1 1-AE21'
Addition Level ofd:
Strain (relevant to Sp
genotype) minimal act' UTP CTP
mediumb
LT2 (wild type) None 36.9
Uracil 29.6
Uridine 28.6
Cytosine 26.8
KD1109 (cdd) None 31.9 3.42 2.21
Uracil 21.6 4.48 2.68
Cytidine 27.8 3.54 4.10
HD11-AE2 None 120 2.52 2.48
(pyrH cdd galE) Uracil 142 2.75 2.70
Cytidine 57.1 1.28 6.20
a Strains were grown in medium A (7) fortified with
FeCl3 6H20 (0.8 ,ug/ml), ZnSO4 7H20 (5 p.g/ml), and
0.2% glucose at 370C to a concentration of approxi-
mately 109 bacterial cells per ml. The cells were
harvested by centrifugation at 17,400 x g for 8 min at
40C, washed with water, and resuspended in 2 ml of
ice-cold 0.05 M Tris-hydrochloride buffer, pH 7.3. The
cell suspension was subjected to ultrasonic disruption
on a sonic oscillator (model SW185; Heat Systems-
Ultrasonics, Plainview, N.Y.) at 0°C for 1 min, centri-
fuged for 30 min at 27,100 x g at 4°C, and assayed for
enzyme activity without further treatment. Cytosine
deaminase activity was determined at 37°C in a 1-ml
assay mixture that contained 50 mM Tris-hydrochlo-
ride buffer (pH 7.3), cell extract, and 0.50 mM cyto-
sine. The decrease in absorbancy at 285 nm was
measured and the product was estimated by using a
molar extinction of 1.038 x 103. Product formation in
the assay was proportional to protein concentration
and time. Protein concentration was determined by the
method of Bradford (5), using lysozyme as the stan-
dard.
b Pyrimidine bases and nucleosides were present at
a final concentration of 50 p.g/ml when added to
medium A.
C Specific activity is expressed as nanomoles of
uracil formed per minute per milligram of protein at
37°C and represents the mean of three separate deter-
minations.
d Data are from reference 10 and are expressed as
micromoles of nucleotide per gram (dry weight) of
bacteria.
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TABLE 3. Effect of pyrimidine limitation on cod gene expression
Strain (relevant genotype) Growth conditions" Sp act'
S2 (pyrA81) Repressing uracil 20.9
Limiting uracil 47.8
JL1055 (pyrA pyrG cdd udp) Repressing uracil and cytidine 24
Limiting uracil, repressing cytidine 69
Repressing uracil, limiting cytidine 75
Limiting uracil and cytidine 78
a Strain S2 was grown at 37°C in medium A (7) to which FeCl3 6H20 (0.8 ,ug/ml), ZnSO4 7H20 (5 ,ug/ml),
arginine (50 p.g/ml), and 0.2% glucose were added v ith either a repressing (50 ,ug/ml) or a limiting (8 ,ug/ml) uracil
concentration. Strain JL1055 was grown at 37°C in medium A (7) which contained added FeCl3-6H20 (0.8 ,ug/ml),
ZnSO4 7H20 (5 p.g/ml), arginine (50 ,g/ml), and 0.4% glucose. The pyrimidine growth conditions of this strain
are represented as follows: repressing uracil and cytidine (50 ,ug/ml each), limiting uracil (2 ,ug/ml) and repressing
cytidine (10 ,ug/ml), repressing uracil (50 ,g/ml) and limiting cytidine (5 ,ug/ml), and limiting uracil and cytidine (5
p.g/ml each). Both strains S2 and JL1055 were starved for the limiting pyrimidine(s) for 90 min after growth had
been arrested at approximately 109 bacterial cells per ml. The pyrimidine-repressed or -starved cells were
harvested and assayed for enzyme activity as described in Table 2, footnote a, except protein was quantitated for
strain JL1055 as previously described (18).
b Specific activity is expressed as nanomoles of uracil formed per minute per milligram of protein at 37°C,
which represents the mean of three separate determinations for strain S2 or the average of two separate
determinations for strain JL1055.
strain. With such elevated UMP levels (10),
especially when grown with uracil (8.4 and 4.8
,umol of UMP per g [dry weight] for pyrH and
pyrH+, respectively), it can be concluded that
UMP is not the repressing metabolite. The effect
of cytidine metabolites on strain HD11-AE2,
with its pronounced 53% decrease in enzyme
activity, was in contrast with the negligible
effect on the activity of the pyrH+ strain
KD11O9 (Table 2). Still, a cytidine compound
appeared to be more effective in repressing
cytosine deaminase synthesis when the strain
was partially limited for pyrimidine nucleotides
(as in strain HD11-AE2). In contrast, a uridine
compound was able to repress synthesis when
pyrimidine ribonucleotide levels were normal
(as in strain KD1109). Therefore, although both
pyrimidine compounds repress synthesis, a uri-
dine compound may be able to interact with the
putative aporepressor with a greater specificity
than a cytidine compound in preventing cod
gene expression.
The pattern of repression of cytosine deami-
nase by pyrimidine compounds does not resem-
ble that of the de novo pyrimidine pathway
enzymes (encoded by pyrA through pyrF) in S.
GLUTAMINE pyrA pyrB pyrC pyrD pyrE
HCO3 - CP C-ASPARTATE -O DHO )-OROTATE >o OMP
ATP ACDAfDTATC cdd I pvrl
CR ' UR
CMP | udp
CD" cod
A C 0 U
CDP
UMP
pyrH
UDP
pyrG
CTP < UTP
FIG. 1. Pathways for de novo and salvage biosynthesis of pyrimidine ribonucleotides in S. typhimurium.
Abbreviations: CP, carbamoyl phosphate; C-ASPARTATE, carbamoyl aspartate; DHO, dihydroorotate; CR,
cytidine; UR, uridine; C, cytosine; U, uracil. Underlined genetic symbols identify the following enzymes: pyrA,
carbamoyl phosphate synthetase (EC 2.7.2.9); pyrB, aspartate carbamoyltransferase (EC 2.1.3.2); pyrC,
dihydroorotase (EC 3.5.2.3); pyrD, dihydroorotate dehydrogenase (EC 1.3.3.1.); pyrE, orotate phosphoribosyl-
transferase (EC 2.4.2.10); pyrF, OMP decarboxylase (EC 4.1.1.23); pyrG, CTP synthetase (EC 6.3.4.2); pyrH,
UMP kinase (EC 2.7.4.4); cdd, cytidine deaminase (EC 3.5.4.5); cod, cytosine deaminase (EC 3.5.4.1); udp,
uridine phosphorylase (EC 2.4.2.3.); upp, uracil phosphoribosyltransferase (EC 2.4.2.9). The dashed line
represents a partially characterized enzymatic reaction.
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typhimurium (Fig. 1). It has been shown that the
de novo enzymes are repressed by either a
uridine or a cytidine compound (10, 16), whereas
cytosine deaminase is repressed by both com-
pounds. This difference in the pattern of repres-
sion of these enzymes in S. typhimurilum may
indicate that cytosine deaminase is regulated by
a distinct regulatory element controlling only
cod gene expression. With cytosine deaminase
being repressed by pyrimidines and with CMP
apparently being enzymatically converted to cy-
tosine (3), greater credibility is lent to the exis-
tence of a biosynthetic salvage pathway for the
conversion of cytidine nucleotides to uridine
nucleotides in S. typhimurium. A possible func-
tion of the pathway might be to recycle RNA
degradation products, using the combined activ-
ities of the CMP degrading enzyme, cytosine
deaminase, and uracil phosphoribosyltransfer-
ase (EC 2.4.2.9) (Fig. 1), in an attempt to main-
tain pyrimidine ribonucleotides at appropriate
levels for RNA synthesis during pyrimidine star-
vation.
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